927 |
Improved Technical Success and Miterm Patency with Subintimal Angioplasty (Compared to Intraluminal Angioplasty in Long Femoropopliteal Occlusions) |
Young-Guk Ko |
Jul. 22. 09 |
926 |
Current Treatment in CLI |
Dierk Scheinert |
Jul. 22. 09 |
925 |
Boston Scientific DES - Current & Future Perspectives |
Keith D. Dawkins |
Jul. 22. 09 |
924 |
SYNTAX - Data Synthesis and Clinical Recommendations |
Patrick W. Serruys |
Jul. 22. 09 |
923 |
Future Clinical Study for Nobori Stent in Korea |
Seung-Jung Park |
Jul. 22. 09 |
922 |
NOBORI -Clinical Studies Updates |
Gian Battista Danzi |
Jul. 22. 09 |
921 |
Stentdesign Comparison and Clinical Perspectives |
Yutaka Hikichi |
Jul. 22. 09 |
920 |
The Role of Triple Antiplatelet Therapy in Patients with High Risk |
Young-Hoon Jeong |
Jul. 22. 09 |
919 |
Tailoring Treatment to Risk in Antiplatelet Therapy |
Alexandra J. Lansky |
Jul. 22. 09 |
918 |
What Is the Optimal Duration of DAPT Following DES Treatment? |
David E. Kandzari |
Jul. 22. 09 |